Strimvelis
NICE recommends first overseas treatment for use on NHS with GSK ‘bubble baby’ gene therapy
January 4, 2018Sales and Marketing ADA-SCID, GSK, GlaxoSmithKline, NHS, NICE, Strimvelis, bubble baby, pharma
NICE has chalked up a new first in its assessment of treatments for use on the NHS, ruling that the …
GSK’s ‘bubble boy’ gene therapy secures NICE recommendation despite high cost
October 25, 2017Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Strimvelis, pharma
GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase …
GSK’s gene therapy Strimvelis gets European regulatory nod
June 1, 2016Research and Development, Sales and Marketing EU, European Commission, GlaxoSmithKline, Strimvelis, gene therapy, regulation
UK drugmaker GlaxoSmithKline (LSE: GSK) said its gene therapy Strimvelis has secured backing from the European regulators. The European Commission …
Latest content
FibroFind appoints Lee Borthwick as CEO
July 21, 2026
